𝔖 Bobbio Scriptorium
✦   LIBER   ✦

139 Long-Term Outcomes After Institution of Adalimumab Therapy in Pediatric Crohn Disease

✍ Scribed by Joel R. Rosh; Trudy Lerer; Michael C. Stephens; Ryan Carvalho; Marian D. Pfefferkorn; Jonathan Evans; Anne M. Griffiths; Anthony R. Otley; Athos Bousvaros; Andrew B. Grossman; Farhat N. Ashai-Khan; Neal S. Leleiko; David J. Keljo; Marsha H. Kay; Meredith C. Hitch; Shehzad A. Saeed; Maria Oliva-Hemker; David R. Mack; James Markowitz; Jeffrey S. Hyams


Book ID
119432983
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
74 KB
Volume
142
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Immediate and long-term outcomes of cort
✍ Alfreda Krupoves; David R. Mack; Ernest G. Seidman; Colette Deslandres; Vytautas πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 200 KB πŸ‘ 2 views

Background: Although a mainstay of treatment of moderate to severe Crohn's disease (CD), corticosteroids use presents significant challenges because of large interindividual variability in response. Corticosteroid-dependence is of particular concern in children, where high rates have been reported.